In a video message released today, Pierre Kory, M.P.A., MD, president and
chief medical officer of the FLCCC, details how the U.S. government plans to spend $1.2 billion on a
drug that, if approved, will have limited use against COVID-19. At the same time, numerous clinical
trials of ivermectin show that it is highly effective in both the prevention and treatment of multiple
phases of the disease, and yet it continues to be ignored by government and medical authorities.

As one of the world’s experts in the use of ivermectin for COVID-19 I feel compelled today to make a
statement. And that statement is in response to the recent announcement by the US government, that
they’re entering into a contractual agreement with Merck where they’re going to commit $1.2 billion of
taxpayer money in order to enrich Merck for a drug which has already been the source of a
whistleblower complaint, and which has already failed in hospitalized patients. They are now testing in
outpatients, when we already have a drug which is low cost, safe, widely available which has been
proven to work in many phases of disease—not only as outpatients but in in-patients.

And so to do so while we now currently have five published review papers from independent panels
from across the world, showing how effective ivermectin is. We have over 20 randomized control
trials showing large statistically significant benefits in mortality. And yet, we plan on giving money to
a drug company for a drug that is in no way going to surpass what we already have available right now
and can use that money should instead be given to supply ivermectin to the country. This is a colossal
waste of taxpayer money. We know this drug works, we’re seeing it work around the world we now
have evidence from multiple countries who’ve adopted it into their guidelines.

What happened in Mexico is they emptied their hospitals, and they’ve essentially rid the country of
COVID using ivermectin. We just got a report from Argentina, where their program is showing large
reductions in the need for hospitalization. And the crisis in India in a number of states was turned
back, with widespread use of ivermectin. We should not be spending or giving any more money to a
drug company who has behaved in the way that it has around ivermectin.

I need to call attention to how disturbed I am at Merck’s actions on February 5 when they issued a
statement that there was no evidence to support the efficacy of ivermectin. They even called into
question the safety of one of the safest drugs, known in history. That statement was a lie. That was a lie
and it’s hurting patients and it’s caused an incalculable loss of life, and to let that go unanswered is
unacceptable. To commit money to a company who behaves in this way is ridiculous. They should
instead be saddled with a colossal fine and I, we, cannot sit by and let our government do this. If they
fulfill this it will be a staggering waste of time and money, and it continues to ignore the widespread
availability of ivermectin. It has to stop. The US government has to be smarter in how they combat
this pandemic. We already have another tool that we know that can end it and that drug is Ivermectin.